How Will New Bioresorbable Polymer Drug-Eluting Stents Impact DAPT Duration?
Current bioresorbable polymer, everolimus-eluting stent technology appears well suited for abbreviated-duration dual-antiplatelet therapy.
By Ian J. Sarembock, MBChB, MD, FACC, and Dean J. Kereiakes, MD, FACC
